Leerink Partners下调Merus NV评级至"与市场持平" 目标价上调至97美元

美股速递
Oct 06, 2025

投资银行Leerink Partners对生物技术公司Merus NV的投资评级进行了调整,将其评级从此前的"跑赢大盘"下调至"与市场持平"。尽管评级有所下调,但该机构同时上调了目标价,从95美元提升至97美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10